1.75
1.13%
-0.02
I-Mab ADR Aktie (IMAB) Neueste Nachrichten
(IMAB) - Analyzing I-MAB's Short Interest By Benzinga - Investing.com UK
Investing.com UK
Here's Why IMab Sponsored ADR (IMAB) is Poised for a Turnaround After Losing 26.8% in 4 Weeks - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Patent Law Changes Pose Threat to I-Mab Adr's Drug Candidate Protection - TipRanks.com - TipRanks
TipRanks
I-Mab Announces CMO Transition, Interim Successor Named - TipRanks.com - TipRanks
TipRanks
I-Mab Finalizes Divestiture and Resolves Obligations - TipRanks.com - TipRanks
TipRanks
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga
Piper Sandler cuts I-Mab stock target to $10, keeps overweight rating - Investing.com
Investing.com
IMAB Stock Quote Price and Forecast - CNN
CNN
Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin ... - Nature.com
Nature.com
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 - PR Newswire
PR Newswire
Morningstar's Best- and Worst-Performing Stocks: 2022 - Morningstar
Morningstar
The Cheapest Stock in the World - Morningstar.ca
Morningstar.ca
10 of the Cheapest Stocks of 2022 - Morningstar
Morningstar
Why Are Some China Healthcare Stocks Up 50%? - Morningstar HK
Morningstar HK
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Scenari Economici
Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial ... - Nature.com
Nature.com
Here's Why IMab Sponsored ADR (IMAB) is Poised for a Turnaround After Losing 26.8% in 4 Weeks - Yahoo Movies UK
Yahoo Movies UK
The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar
Morningstar
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket By Benzinga - Investing.com UK
Investing.com UK
Markets Brief: How High Can Mortgage Rates Go? - Morningstar
Morningstar
New 5-Star Stocks - Morningstar
Morningstar
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
InvestorPlace
10 biotechs to know in China - FiercePharma
FiercePharma
I-Mab (IMAB) Stock Price, News & Analysis - NASDAQ - MarketBeat
MarketBeat
Notch2 activation ameliorates nephrosis - Nature.com
Nature.com
Kapitalisierung:
|
Volumen (24h):